Annual Cash & Cash Equivalents
$12.62 M
-$539.00 K-4.10%
December 31, 2023
Summary
- As of February 6, 2025, CRVS annual cash & cash equivalents is $12.62 million, with the most recent change of -$539.00 thousand (-4.10%) on December 31, 2023.
- During the last 3 years, CRVS annual cash & cash equivalents has fallen by -$3.83 million (-23.31%).
- CRVS annual cash & cash equivalents is now -80.11% below its all-time high of $63.46 million, reached on December 31, 2021.
Performance
CRVS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$4.68 M
-$10.16 M-68.47%
September 30, 2024
Summary
- As of February 6, 2025, CRVS quarterly cash and cash equivalents is $4.68 million, with the most recent change of -$10.16 million (-68.47%) on September 30, 2024.
- Over the past year, CRVS quarterly cash and cash equivalents has dropped by -$15.43 million (-76.72%).
- CRVS quarterly cash and cash equivalents is now -95.44% below its all-time high of $102.56 million, reached on March 31, 2018.
Performance
CRVS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CRVS Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.1% | -76.7% |
| 3 y3 years | -23.3% | -64.4% |
| 5 y5 years | -67.8% | -64.4% |
CRVS Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -80.1% | at low | -92.6% | at low |
| 5 y | 5-year | -80.1% | +144.9% | -93.5% | at low |
| alltime | all time | -80.1% | +207.4% | -95.4% | +15.1% |
Corvus Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.68 M(-68.5%) |
| Jun 2024 | - | $14.84 M(+99.0%) |
| Mar 2024 | - | $7.46 M(-40.9%) |
| Dec 2023 | $12.62 M(-4.1%) | $12.62 M(-37.2%) |
| Sep 2023 | - | $20.11 M(+162.5%) |
| Jun 2023 | - | $7.66 M(-20.7%) |
| Mar 2023 | - | $9.65 M(-26.6%) |
| Dec 2022 | $13.16 M(-79.3%) | $13.16 M(-46.5%) |
| Sep 2022 | - | $24.59 M(-13.7%) |
| Jun 2022 | - | $28.48 M(-9.5%) |
| Mar 2022 | - | $31.46 M(-50.4%) |
| Dec 2021 | $63.46 M(+285.6%) | $63.46 M(-12.2%) |
| Sep 2021 | - | $72.30 M(+22.7%) |
| Jun 2021 | - | $58.91 M(+30.6%) |
| Mar 2021 | - | $45.10 M(+174.1%) |
| Dec 2020 | $16.45 M(+219.3%) | $16.45 M(-28.4%) |
| Sep 2020 | - | $22.98 M(+11.0%) |
| Jun 2020 | - | $20.70 M(-11.9%) |
| Mar 2020 | - | $23.50 M(+355.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $5.15 M(-86.9%) | $5.15 M(-43.2%) |
| Sep 2019 | - | $9.07 M(-70.0%) |
| Jun 2019 | - | $30.18 M(-22.6%) |
| Mar 2019 | - | $38.98 M(-0.6%) |
| Dec 2018 | $39.20 M(-13.1%) | $39.20 M(-3.8%) |
| Sep 2018 | - | $40.75 M(+45.2%) |
| Jun 2018 | - | $28.07 M(-72.6%) |
| Mar 2018 | - | $102.56 M(+127.4%) |
| Dec 2017 | $45.11 M(+793.2%) | $45.11 M(+2.3%) |
| Sep 2017 | - | $44.10 M(+29.4%) |
| Jun 2017 | - | $34.09 M(+225.1%) |
| Mar 2017 | - | $10.49 M(+107.7%) |
| Dec 2016 | $5.05 M(+23.0%) | $5.05 M(-9.4%) |
| Sep 2016 | - | $5.58 M(+28.4%) |
| Jun 2016 | - | $4.34 M(+6.8%) |
| Mar 2016 | - | $4.07 M(-1.0%) |
| Dec 2015 | $4.11 M(-67.2%) | $4.11 M(-94.8%) |
| Sep 2015 | - | $79.60 M |
| Dec 2014 | $12.52 M | - |
FAQ
- What is Corvus Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Corvus Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Corvus Pharmaceuticals?
- What is Corvus Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Corvus Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of CRVS is $12.62 M
What is the all time high annual cash & cash equivalents for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high annual cash & cash equivalents is $63.46 M
What is Corvus Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, CRVS annual cash & cash equivalents has changed by -$539.00 K (-4.10%)
What is Corvus Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CRVS is $4.68 M
What is the all time high quarterly cash and cash equivalents for Corvus Pharmaceuticals?
Corvus Pharmaceuticals all-time high quarterly cash and cash equivalents is $102.56 M
What is Corvus Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, CRVS quarterly cash and cash equivalents has changed by -$15.43 M (-76.72%)